Anwesha Kar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Mettl3-Dnmt3b Axis Shapes CD8⁺ T Cell Differentiation and Anti-Tumor Immunity
  2026 DOI: 10.2139/ssrn.7119113
  +Save
• S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors
  EMBO Reports 2026 DOI: 10.1038/s44319-026-00734-3
  +Save
• Data from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.c.6513990
  +Save
• Supplementary Data from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698924
  +Save
• Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698921
  +Save
• Table S2 and S3 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2025 DOI: 10.1158/0008-5472.30698918
  +Save
• CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor
  Science Advances 2025 DOI: 10.1126/sciadv.adt2117
  +Save
• CD38–RyR2 axis–mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer
  Proceedings of the National Academy of Sciences 2024 DOI: 10.1073/pnas.2315989121
  +Save
• Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2023 DOI: 10.1158/0008-5472.23533742
  +Save
• Supplementary Table from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
  2023 DOI: 10.1158/0008-5472.22431795
  +Save